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Abstract
Bee venom contains a variety of peptides and enzymes, including serine proteases. While the presence of serine proteases
in bee venom has been demonstrated, the role of these proteins in bee venom has not been elucidated. Furthermore, there
is currently no information available regarding the melanization response or the fibrin(ogen)olytic activity of bee venom
serine protease, and the molecular mechanism of its action remains unknown. Here we show that bee venom serine
protease (Bi-VSP) is a multifunctional enzyme. In insects, Bi-VSP acts as an arthropod prophenoloxidase (proPO)-activating
factor (PPAF), thereby triggering the phenoloxidase (PO) cascade. Bi-VSP injected through the stinger induces a lethal
melanization response in target insects by modulating the innate immune response. In mammals, Bi-VSP acts similarly to
snake venom serine protease, which exhibits fibrin(ogen)olytic activity. Bi-VSP activates prothrombin and directly degrades
fibrinogen into fibrin degradation products, defining roles for Bi-VSP as a prothrombin activator, a thrombin-like protease,
and a plasmin-like protease. These findings provide a novel view of the mechanism of bee venom in which the bee venom
serine protease kills target insects via a melanization strategy and exhibits fibrin(ogen)olytic activity.
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Introduction
Bee venom serves as a defensive weapon against intruders (such as
animals), and it contains a variety of enzymes, peptides, and biogenic
amines [1–4]. Bee stings can cause life-threatening allergic reactions
due to an immediate hypersensitivity-induced reaction that leads to
anaphylaxis [5,6]. Two of the more commonly encountered species
o fb e ea r et h eh o n e y b e e( Apis mellifera), which is a representative
beneficial insect for humans, and the bumblebee (Bombus spp.), which
is commonly used in greenhouses and fields to pollinate crops [7].
The amount of venom released by a honeybee sting is approximately
5-times greater than that released by a bumblebee sting [8]. Unlike
honeybees, however, bumblebees can sting multiple times and do not
lose their stingers. Bumblebee venom appears to be highly cross-
reactive with honeybee venom [1]. Additionally, bee venom has been
used as a traditional medicine to treat a variety of diseases, including
arthritis,rheumatism,pain,canceroustumors,andskindiseases[4,9].
Better knowledge of the components of bee venom would be useful
for improving therapeutic treatments for allergic reactions to bee
stings [1], developing an immunotherapy for bee venom hypersen-
sitivity [6,10], and investigating the mechanism underlying venom
therapy in alternative medicine [4,11].
Previous studies have demonstrated the presence of serine
proteases in bee venom [1,2,12]. Bee venom serine proteases,
which consist of a single serine protease domain, are considered
important allergens that have significant IgE binding activity
[1,2,10]. Compared to honeybee venom, bumblebee venom
contains a larger amount of serine proteases [12].
Serine proteases are found in diverse organisms and share many
biochemical and structural properties, including a conserved
catalytic triad (Ser, His, and Asp) that represents the main
criterion for classification of a protein as a serine protease. Serine
proteases have diverse functions and play roles in digestion, the
immune response, complement activation, cellular differentiation,
and hemostasis [13,14]. In snake venom, a number of serine
proteases show fibrin(ogen)olytic activity that acts in hemostasis
and thrombosis in mammals [15–18]. The fibrin(ogen)olytic
activity of snake venom serine proteases, which inhibits blood
coagulation in victims, serves as a mechanism to facilitate the
spread of toxic components throughout the bloodstream. In
arthropods, an immune challenge triggers a serine protease
cascade that leads to the activation of prophenoloxidase
(proPO)-activating factors (PPAFs), which are also called proPO-
activating enzymes (PPAEs) or proteinases (PAPs) [19,20]. PPAFs
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domains. Once activated, PPAFs convert proPO to phenoloxidase
(PO), which then catalyzes the production of quinones to form
melanin.
While mounting evidence points to the serine protease
component of bee venom as an important allergen [1,3,12],
the molecular function of the bee venom serine protease, unlike
other major components, has not been studied. Furthermore,
snake venom serine proteases haveb e e ne x t e n s i v e l yc h a r a c t e r -
ized [15–18], but the roles of these proteins in bee venom
remain unknown. Here we demonstrate that bumblebee (Bombus
ignitus) venom serine protease (Bi-VSP) is a multifunctional
enzyme that functions in a different manner in arthropods and
mammals.
Results and Discussion
Bi-VSP Possesses a Domain Structure Similar to PPAF and
Snake Venom Serine Protease
To explore the role of serine proteases in bee venom, we
identified an expressed sequence tag (EST) for a gene encoding a
venom serine protease (Bi-VSP) in the bumblebee Bombus ignitus.
The Bi-VSP gene consists of six exons encoding a 360-amino acid
protein (Figure S1). The predicted Bi-VSP protein contains
features consistent with catalytic PPAFs, including a catalytic
triad (His, Asp, and Ser) in the serine protease domain and a single
clip domain (Figures 1A & S2) [20,21]. In addition, the catalytic
triad in the serine protease domain of Bi-VSP is consistent with
snake venom serine proteases (Figures 1A & S3) [15,16]. Thus,
Figure 1. Bi-VSP is a secreted protein with a domain structure similar to those of PPAF and snake venom serine protease. (A) The
domain structures of Bi-VSP, PPAF, and snake venom serine protease: hydrophobic signal sequence (red), carboxy-terminal serine protease (SP)
domain (orange), single amino-terminal clip domain (blue), cleavage site (arrowhead), and residues in the catalytic triad of the SP (H, D, and S). (B)
Expression of Bi-VSP. Protein obtained from the venom gland, venom sac, and secreted venom of B. ignitus worker bees was analyzed using SDS-
PAGE (left) and western blot (right). Bi-proVSP and Bi-VSP are shown. The arrowhead on the left indicates the position of Bi-proVSP.
doi:10.1371/journal.pone.0010393.g001
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PPAF and snake venom serine protease.
We examined the pattern of Bi-VSP expression to confirm that it
is a component of bee venom. Bi-VSP exhibits venom gland-
specific expression (Figure S4). An anti-Bi-proVSP antibody was
generated using a recombinant Bi-VSP precursor (40-kDa Bi-
proVSP) expressed in baculovirus-infected insect cells (Figure S5).
The antibody was used to demonstrate the presence of Bi-VSP in
the venom gland, venom sac, and in secreted venom (Figure 1B).
The form of Bi-VSP detected in bee venom was the 34-kDa
mature protein, which is created by cleavage of the catalytic
domain of Bi-proVSP between Arg113 and Val114 (Figure S1A).
This result is consistent with data characterizing other PPAFs
[20,21] and snake venom serine proteases [15], which are
expressed as zymogens that are activated by proteolytic cleavage.
Taken together, these data indicate that Bi-proVSP is produced in
the venom gland, gets cleaved into its 34-kDa active form (mature
Bi-VSP), and is then stored in the venom sac.
Bi-VSP Acts as a PPAF That Activates a Lethal
Melanization Response
We first identified Bi-VSP as a PPAF, and we propose that it is
involved in the activation of proPO and in the subsequent
melanization response in target insects. Initially, we aimed to
determine whether Bi-VSP is capable of activating the PO cascade
in a target insect [21], and if so, whether the melanization response
adversely affects the target insect [22]. To examine this issue, we
selected the Bombyx mori silkworm as a model target insect because
the proPOs in the PO cascade of this insect have been
characterized [23–25]. Purified Bi-VSP was injected into fifth-
instar B. mori larvae (Figure S6) and PO activity was measured
(Figure 2A). The PO activity increased for 3 h in the injected
larval hemolymph and continued to increase at a slower rate
thereafter. No PO activity was detected upon injection of Bi-
proVSP, indicating that Bi-proVSP was not cleaved into the active
Bi-VSP in B. mori larvae. To determine whether Bi-VSP induces
cell death via melanization, immunofluorescent staining of the
larval cells was performed. Cell death in the hemocytes and fat
bodies was significant in the Bi-VSP-treated larvae 6 h post-
injection (p.i.) but was not detected in the Bi-proVSP-treated
larvae (Figure 2B).
To assess whether the Bi-VSP-induced PO activity observed in
B. mori larvae was due to cleavage of B. mori proPOs, recombinant
B. mori proPO-I (BmPPO-I) and proPO-II (BmPPO-II) were
produced in insect cells (Figure S7). Purified BmPPO-I and
BmPPO-II were then incubated with Bi-VSP or Bi-proVSP.
Further defining the role of Bi-VSP as a bee venom PPAF, Bi-VSP
cleaved BmPPO-I and BmPPO-II and enhanced PO activity
(Figure 2C). Although Bi-VSP cleaved B. mori proPOs in both the
presence and absence of Ca
2+, cleavage was more efficient in the
presence of Ca
2+, indicating that Bi-VSP is at least partially
dependent on Ca
2+ for optimal induction of PO activity [26,27].
Given that we observed proPO activation by Bi-VSP both in vivo
and in vitro, these data provide biochemical evidence that Bi-VSP is
a PPAF enzyme that activates proPO in the insect proPO cascade.
We reasoned that the PO cascade would not be activated if Bi-
VSP was excluded from the bee venom. A sample of bee venom
lacking Bi-VSP was prepared by separating the venom compo-
nents using size-exclusion chromatography. The Bi-VSP-contain-
ing fractions, which were identified using SDS-PAGE and western
blot, were excluded from the remainder of the venom (Figure 2D).
We then injected bee venom with or without Bi-VSP into B. mori
larvae and measured PO activity. Bee venom lacking Bi-VSP was
unable to activate proPO or induce melanization (Figure 2D).
These results indicate that the PO cascade triggered by bee venom
is Bi-VSP-dependent, thereby defining a specific role for Bi-VSP in
bee venom.
We also examined the Bi-VSP-mediated activation of proPO
and melanization in larvae of Spodoptera exigua (beet armyworm)
and Pieris rapae (Chinese cabbage worm) (Figure 3A). Both PO
activity and melanization developed more rapidly and extensively
in the hemolymph of S. exigua and P. rapae larvae injected with Bi-
VSP than in the Bi-VSP-treated B. mori larvae, which may be due
to differences in larval body size and hemolymph volume. The
activation of a melanization response in S. exigua, P. rapae, and B.
mori by Bi-VSP suggests that Bi-VSP may activate the PO cascade
in a broad range of insects. We assessed whether Bi-VSP activation
of the PO cascade plays a role in killing target insects by assaying
the mortality rates of fifth-instar S. exigua larvae injected with 1 or
2 mg of Bi-VSP. All injected larvae exhibited melanization at 1 h
p.i. (Figure S8A) and a 100% mortality within 36 h p.i. (Figure
S8B). Our observations indicate that, unlike the toxic functions of
other arthropod venom components identified to date [28–31], Bi-
VSP activates a melanization response and ultimately induces the
death of the target insect, demonstrating that excessive melaniza-
tion due to hyperactivation of the proPO system can fatally
damage an insect.
Two major components of honeybee venom are melittin and
phospholipase A2 (PLA2). Melittin is the most abundant venom
constituent [32] and is biologically similar to bombolitin [33].
PLA2 is the best-characterized toxic venom enzyme [34]. We
previously identified PLA2 (Bi-PLA2) [35] and bombolitin (Bi-
Bombolitin) [36] in B. ignitus venom. SDS-PAGE analysis
revealed that Bi-Bombolitin, Bi-PLA2, and Bi-VSP constitute
the three major components of B. ignitus venom (Figure 3B). To
address whether Bi-VSP and other venom components act
cooperatively to increase toxicity, Bi-PLA2 and Bi-Bombolitin
were injected into S. exigua larvae singly or in combination with or
without Bi-VSP. Among the three venom components, Bi-VSP
was the most toxic to S. exigua larvae, followed by Bi-PLA2
(Figures 3B & S9). The survival time of larvae injected with Bi-
PLA2 and Bi-Bombolitin was significantly shortened when these
compounds were combined with Bi-VSP (Figure 3B), demon-
strating that the increased toxicity is due to melanization. These
results indicate that Bi-VSP acts synergistically with other venom
components to enhance toxicity. Given that each bee venom
component is required, the combination of other components
and Bi-VSP that serves to elicit melanization is an efficient way to
induce lethality.
In arthropods, PPAFs play a critical role in proPO activation
[19], and successful parasitism requires inhibition of proPO
activation by PPAF as an anti-melanization strategy [37].
Mutation of a signaling protease required for PPAF activation
in the melanization cascade affects resistance and tolerance of
infections in Drosophila [38]. However, hyperactivation of the PO
cascade can induce melanization and adversely affect the insect’s
immune response [22]. Thus, hyperactivation of the PO cascade
by injection of an active PPAF such as Bi-VSP is a melanization
strategy that uses the target’s own immune defense mechanisms.
Based on the role of Bi-VSP and the arthropod proPO-activating
system [19], we propose a pathway with a defined role for Bi-VSP
in proPO activation (Figure S10). The pathway begins with
injection of Bi-VSP through the stinger into the target insect. Bi-
VSP then converts inactive proPO to active PO, thereby
triggering the PO cascade and inducing a lethal melanization
response. Thus, our results define a role for bee venom serine
protease in the induction of melanization that results in the death
of target insects.
Bee Venom Serine Protease
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Fibrin(ogen)olytic Enzyme
Due to the fact that Bi-VSP has His, Asp, and Ser residues in
positions corresponding to the catalytic triad identified in snake
venom serine proteases (Figure S3), we investigated whether
Bi-VSP functions in a fashion similar to snake venom serine
proteases, which exhibit fibrin(ogen)olytic activity [15–18]. To
address this issue, we analyzed the time course of human
prothrombin cleavage by Bi-VSP and found that thrombin was
the major cleavage product (Figure 4). This shows that Bi-VSP
Figure 2. Bi-VSP acts as a PPAF. (A) PO activity in the hemolymph of fifth-instar B. mori larvae injected with Bi-VSP (5 mg/larva), Bi-proVSP (5 mg/
larva), or phosphate-buffered saline (PBS, 30 ml/larva). PO activity is expressed as the mean 6 SD (n=3). (Inset) B. mori larvae and hemolymph 12 h p.i.
(B) Immunofluorescent staining of hemocytes and fat bodies in fifth-instar B. mori larvae injected with Bi-proVSP (5 mg/larva) or Bi-VSP (5 mg/larva).
Apoptosis (green) of hemocytes and fat bodies is visible. Bi-proVSP was used as a negative control. Scale bar, 10 mm. (C) The effects of Bi-VSP on PO
activity and on the cleavage of B. mori proPOs. Purified BmPPO-I (left) and BmPPO-II (right) were incubated with Bi-VSP or Bi-proVSP in the presence
or absence of Ca
2+. Cleavage of the His-tagged recombinant BmPPO-I and BmPPO-II into BmPO-I and BmPO-II was detected using a western blot with
an anti-His antibody. (D) Bee venom lacking Bi-VSP was unable to activate proPO cleavage and melanization. SDS-PAGE (left) and western blot
(middle) showing crude venom and venom lacking Bi-VSP (venomDBi-VSP). PO activity (right) in the hemolymph of fifth-instar B. mori larvae injected
with crude venom or venomDBi-VSP (5 mg/larva) is expressed as the mean 6 SD (n=3). (Inset) B. mori larvae and hemolymph 12 h p.i.
doi:10.1371/journal.pone.0010393.g002
Figure 3. Bi-VSP activates a lethal melanization response. (A) PO activity in the hemolymph of fifth-instar S. exigua larvae (left) or P. rapae
larvae (right) injected with Bi-VSP (2 mg/larva) or PBS (10 ml/larva). The PO activity is expressed as the mean 6 SD (n=3). (Insets) S. exigua larvae, P.
rapae larvae, and hemolymph 12 h p.i. (B) Toxicity of bee venom components in S. exigua larvae. Bi-VSP, Bi-PLA2, and Bi-Bombolitin purified from B.
ignitus venom were detected using SDS-PAGE (left). Day 2 fifth-instar S. exigua larvae were injected with 2 mg/larva of Bi-VSP, Bi-PLA2, Bi-Bombolitin,
Bi-VSP + Bi-PLA2, Bi-VSP + Bi-Bombolitin, Bi-PLA2 + Bi-Bombolitin, or Bi-VSP + Bi-PLA2 + Bi-Bombolitin. The median survival time (ST50) was determined
(n=51), and injected S. exigua larvae were photographed at 24 h p.i. (right).
doi:10.1371/journal.pone.0010393.g003
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activator. Based on the cleavage pattern observed during
prothrombin activation, Bi-VSP converts prothrombin into
thrombin in a manner similar to the mammalian blood
coagulation factor Xa [39] (data not shown), as demonstrated
for snake venom prothrombin activators [17,40].
We then assessed whether Bi-VSP possesses direct fibrin(ogen)oly-
tic activity by analyzing the time course of human fibrinogen
degradation by Bi-VSP (Figure 5A). SDS-PAGE analysis revealed
that the Aa,B b,a n dc chains of human fibrinogen disappeared
within 2 h and were replaced by fibrin degradation products. To
obtain direct evidence that Bi-VSP degrades fibrin, we assayed
fibrinolytic activity using the fibrin plate method. This showed that
addition of Bi-VSP led to the formation of a clear hollow (Figure 5B).
The size of the clear hollow was dependent on the incubation time
and the Bi-VSP dose. These results show that Bi-VSP not only
converts fibrinogen into fibrin but also degrades fibrin into
degradation products similar to those obtained using plasmin
[41,42], indicating that Bi-VSP acts as both a thrombin-like protease
and a plasmin-like protease. We next addressed whether Bi-VSP is
involved in the activation of plasminogen. There was no band
corresponding to plasmin on SDS-PAGE, indicating that Bi-VSP is
not a plasminogen activator (data not shown).
Thus, in addition to displaying PPAF activity, Bi-VSP also
displays fibrin(ogen)olytic activity similar to snake venom serine
proteases [15–18]. Our results define roles for Bi-VSP as a
thrombin-like protease, as a plasmin-like protease, and as a
prothrombin activator (Figure S10). This suggests that Bi-VSP
affects at least three steps in the hemostatic system [15,16,43]. The
prothrombin activation and fibrin(ogen)olytic protease activities of
Bi-VSP may cooperate to effectively remove fibrinogen and
thereby reduce blood viscosity [44,45]. Our results therefore
suggest that injection of the fibrin(ogen)olytic enzyme Bi-VSP is
used to facilitate the spread of bee venom components throughout
the bloodstream in mammals, as has been demonstrated for snake
venom fibrin(ogen)olytic enzymes, which alter blood rheology by
decreasing the concentration of blood fibrinogen [18,44,45]. Our
finding that bee venom serine protease possesses fibrin(ogen)olytic
activity has significant implications for the use of bee venom as a
potential clinical agent in the medical and pharmacological fields
of hemostasis and thrombosis [11,18].
Conclusion
In this present study, we provide the first evidence that bee
venom serine protease functions analogously to both an arthropod
PPAF and a snake venom serine protease. Furthermore, our
findings highlight a rationale for the presence of a serine protease
in bee venom: Bi-VSP acts as a PPAF to induce a lethal
melanization response in arthropods and as a fibrin(ogen)olytic
enzyme to facilitate the spread of bee venom components
throughout the bloodstream in mammals. The finding that bee
venom serine protease functions with a different mechanism of
action in arthropods and mammals highlights the two-pronged
strategy possible with bee venom serine protease.
Materials and Methods
Insects
The B. ignitus, B. mori, S. exigua, and P. rapae used in this study
were supplied by the Department of Agricultural Biology, National
Academy of Agricultural Science, Republic of Korea. B. ignitus, B.
mori, and S. exigua were reared as previously described [46–48]. P.
rapae was reared on fresh Chinese cabbage leaves at 25uC under
conditions of 6565% relative humidity using a 12 h light:12 h
dark photoperiod.
Figure 4. Bi-VSP activates prothrombin. SDS-PAGE analysis shows
activation of human prothrombin by Bi-VSP. The number indicates the
time (min) that prothrombin was incubated with Bi-VSP. Prothrombin
and thrombin are shown.
doi:10.1371/journal.pone.0010393.g004
Figure 5. Bi-VSP possesses fibrin(ogen)olytic activity. (A) SDS-PAGE analysis of human fibrinogen hydrolysis by Bi-VSP. The number indicates the
time (min) that fibrinogen was incubated with Bi-VSP. Human fibrinogen chains and fibrin degradation products (FDPs) are shown. (B) Detection of the
enzymatic activity of Bi-VSP on fibrin plates. Bi-VSP (1, 2, 3, or 5 mg) was dropped onto a fibrin plate and incubated at 37uC for various periods of time.
doi:10.1371/journal.pone.0010393.g005
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A clone encoding the Bi-VSP insert was selected from ESTs
generated from a cDNA library created using venom glands
from B. ignitus worker bees [35]. Plasmid DNA was extracted using
the Wizard Mini-Prep Kit (Promega) and sequenced using an
ABI 310 automated DNA sequencer (Perkin-Elmer Applied
Biosystems). Sequences were compared using the DNASIS
and BLAST programs (http://www.ncbi.nlm.nih.gov/BLAST).
Genomic DNA was extracted from the fat body tissue of B. ignitus
workers using the Wizard Genomic DNA Purification Kit
(Promega); this was then used as a template for PCR. The
sequences of the oligonucleotide primers used for amplification
were forward 1 (1–24), 59-ATGACGGGCTCCAAGATGC-
TGTTC-39 and reverse 1 (363–340), 59-TACAGCTGGCTTAC-
CACCGACCAC-39; forward 2 (340–363), 59-GTGGTCGGT-
GGTAAGCCAGCTGTA-39 and reverse 2 (1083–1060), TTA-
TTGCATCGCTGGGAGAATAAA-39. The amplification prim-
ers were designed using Bi-VSP cDNA sequences. All PCR
products were verified by DNA sequence analysis.
Tissue collection
B. ignitus worker bees were dissected on ice using a stereo
microscope (Zeiss, Jena, Germany). Tissue samples (fat body,
venom gland, and venom sac) were collected and washed with PBS
(140 mM NaCl, 27 mM KCl, 8 mM Na2HPO4, 1.5 mM
KH2PO4, pH 7.4). Hemolymph was collected in cold test tubes
by puncturing the body of B. ignitus worker bees or by cutting the
legs of B. mori, S. exigua, and P. rapae larvae. The hemolymph was
centrifuged at 10,0006g for 10 min to remove the hemocytes and
cell debris. The collected tissue samples were used without further
processing.
RNA extraction and northern blot
Total RNA was isolated from the fat body, midgut, muscle,
venom gland, and venom sac using a Total RNA Extraction Kit
(Promega). The total harvested RNA (5 mg/lane) was separated in
a 1.0% formaldehyde agarose gel, transferred onto a nylon
blotting membrane (Schleicher & Schuell, Dassel, Germany), and
hybridized at 42uC with a probe in hybridization buffer containing
56 SSC, 56Denhardt’s solution, 0.5% SDS, and 100 mg/ml of
denatured salmon sperm DNA. The Bi-VSP cDNA was labeled
with [a-
32P]dCTP (Amersham Biosciences) using the Prime-It II
Random Primer Labeling Kit (Stratagene), and the labeled cDNA
was used as a probe for hybridization. After hybridization, the
membrane filter was washed three times for 30 minutes each in
0.1% SDS and 0.26 SSC at 65uC and then exposed to
autoradiography film.
Protein expression
A baculovirus/Sf9 insect cell expression system [49] was used
for the production of recombinant Bi-proVSP proteins. A Bi-
proVSP cDNA fragment containing the full-length open reading
frame (ORF) was inserted into the pBAC1 vector (Clontech) to
generate expression vectors that drive the expression of the
recombinant protein under the control of the Autographa californica
nucleopolyhedrovirus (AcNPV) polyhedrin promoter. Recombi-
nant baculoviruses were propagated in Sf9 cells cultured in TC100
medium (Gibco BRL) at 27uC. Recombinant proteins were
purified using a HisTrap column (Amersham Biosciences) and
injected into BALB/c mice to produce a polyclonal antibody [50].
The protein concentration was determined using the Bio-Rad
Protein Assay Kit. The protein samples were mixed with sample
buffer, boiled for 5 min, and separated using 12% or 14% SDS-
PAGE. Western blots were performed as described previously [50]
using an Enhanced Chemiluminescence Western Blotting Detec-
tion System (Amersham Biosciences).
Venom component purification and N-terminal
sequencing
The complete sting apparatus was removed from each of ,800
worker bees after anesthesia was induced by chilling. Venom sacs
were cut free and immersed in PBS and the supernatant was
collected after centrifugation at 10,0006g for 10 min. Bi-VSP, Bi-
PLA2, and Bi-Bombolitin were purified from the supernatant by
size-exclusion column chromatography. Size-exclusion chroma-
tography was performed at a flow rate of 0.5 ml/min using a
HiPrep 16/60 Sephacryl S-100 column (Amersham Biosciences)
equilibrated with 0.05 M sodium phosphate buffer (pH 7.2)
containing 0.15 M NaCl. Purified Bi-VSP, Bi-PLA2, and Bi-
Bombolitin were identified by SDS-PAGE. To prepare bee venom
lacking Bi-VSP, venom components were separated using size-
exclusion chromatography as described above. The Bi-VSP-
containing fractions, which were identified using SDS-PAGE
and western blot, were excluded from the remainder of the venom.
The Bi-VSP-lacking fractions were concentrated using SpeedVac
centrifugation. The purified proteins were transferred to a
polyvinylidene difluoride membrane (Applied Biosystems), stained,
excised, and subjected to automated Edman degradation using a
protein sequencer (Procise 491 HT Protein sequencer, Applied
Biosystems).
Experimental injections
The larvae were injected with sample solution between the sixth
and seventh abdominal segments using a sterile needle. Prior to
injection, the larvae were placed on ice for 5 min. After the
injection, the injected site on each larva was covered with paraffin
[47].
Immunofluorescent staining
Day 2 fifth-instar B. mori larvae were injected with the 40-kDa
Bi-proVSP or the 34-kDa Bi-VSP. Fat body tissues and hemocytes
were collected at 1, 3, 6, 12, and 24 h p.i. Fat body tissues were
fixed in 4% neutral buffered paraformaldehyde (NBP) for 12 h
and cryoprotected by immersion in 20% sucrose phosphate buffer
at 4uC for 24 h. The tissues were frozen using an optimal cutting
temperature compound (Sakura Finetechnical Co., Japan), after
which 10 mm sections were cut. The sections were thaw-mounted
on slides at room temperature and stored at 270uC until use.
Hemocytes were isolated from the hemolymph by centrifugation
at 2006g for 10 min at 4uC prior to air-drying and fixing the
samples in 4% NBP on glass slides. Apoptosis was assayed using
the terminal deoxynucleotidyl transferase-mediated dUTP nick
end labeling (TUNEL) technique in fat body tissues and
hemocytes according to the protocol provided with the in situ cell
death detection kit (Roche Applied Science). The samples were
incubated in a TUNEL reaction mixture containing terminal
deoxynucleotidyl transferase and fluorescein-conjugated dUTP at
37uC for 1 h. Apoptosis in the tissues was analyzed by laser
scanning confocal microscopy (Carl Zeiss LSM 510, Zeiss).
PO activity assay in hemolymph
The assay for PO activity in hemolymph was carried out as
previously described [51]. Hemolymph from fifth-instar B. mori,
S. exigua, and P. rapae larvae injected with the compounds was
collected individually at various time points. To obtain cell-free
hemolymph, the samples were centrifuged at 8006g for 5 min at
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Three independent measurements of PO activity were performed.
The mean values with their respective error bars are shown.
proPO cleavage and activity assays
B. mori PPO-I (BmPPO-I) and PPO-II (BmPPO-II) cDNAs were
reverse transcribed using the following primer sets: 59-GGATC-
CATGCTGACGCCAAGAACAAC-39 (forward) and 59-CT-
CGAGCCCCTGCTGGCCGCGCTGGCG-39 (reverse) for
BmPPO-I (GenBank accession no. NM_001043870) and 59-
GGATCCATGGCTGACGTTTTTGAAAGC-39 (forward) and
59-GCGGCCGCAACTGACATGGGAGGGTTCCG-39 (re-
verse) for BmPPO-II (GenBank accession no. NM_001112747).
BmPPO-I and BmPPO-II cDNA fragments containing the full-
length ORFs were inserted into the pBAC1 vector (Clontech) to
express the recombinant protein under the control of the AcNPV
polyhedrin promoter. Recombinant baculoviruses were propagat-
ed in Sf9 cells cultured in TC100 medium (Gibco BRL) at 27uC.
The recombinant proteins were purified using a HisTrap column
(Amersham Biosciences). The effect of 34-kDa Bi-VSP and 40-kDa
Bi-proVSP on the cleavage of B. mori proPOs was examined using
purified components. BmPPO-I (1 mg) or BmPPO-II (1 mg) and
purified Bi-VSP (0.5 mg) or Bi-proVSP (0.5 mg) were added to
20 ml of aqueous buffer (20 mM Tris-HCl, pH 8.0) in the presence
or absence of 5 mM CaCl2. Samples were incubated at 30uC for
10 minutes and analyzed by western blot with an anti-His
antibody (Clontech). Samples were also added to 980 mlo f
substrate solution (20 mM L-dopamine in 20 mM Tris-HCl
buffer, pH 8.0), and PO activity was measured at 490 nm [51].
Toxicity assay
To compare the toxicity of the venom components, day 2 fifth-
instar S. exigua larvae were injected with venom components
individually and in combination. Larvae were injected with 2 mg/
larva of Bi-PLA2, Bi-Bombolitin, Bi-VSP, Bi-VSP + Bi-PLA2, Bi-
VSP + Bi-Bombolitin, Bi-PLA2 + Bi-Bombolitin, or Bi-VSP + Bi-
PLA2 + Bi-Bombolitin. The accumulated mortality was measured
for 72 h p.i. The median survival time (ST50) was calculated using
the Probit method and the SoftTOX software, version 1.1
(WindowChem Inc., USA). The 95% confidence intervals (CI)
were also calculated for the ST50 values.
Prothrombin activation assay
A prothrombin activation assay was performed as previously
described [52,53]. Human prothrombin (2 mg, Sigma) was
incubated with 2 ng of Bi-VSP in 50 mM Tris-HCl buffer
(pH 8.0) containing 100 mM NaCl and 5 mM CaCl2 at 37uC
for various periods of time. Aliquots were removed at various time
points and analyzed using 14% SDS-PAGE.
Fibrinogen cleavage assay
A fibrinogen cleavage assay was performed as previously
described [54]. Human fibrinogen (10 mg, MP Biomedicals) was
incubated with 0.25 mg of Bi-VSP in 50 mM Tris-HCl buffer
(pH 8.0) at 37uC for various lengths of time. Aliquots were
removed at various time points and analyzed using 14% SDS-
PAGE.
Fibrin plate assay
The fibrin plate assay was performed with 5 ml human
fibrinogen (0.5%) clotted with three units of thrombin (Sigma).
Bi-VSP of various concentrations was dropped onto the fibrin
plate and incubated at 37uC for various periods of time.
Fibrinolytic activity was determined by examining the formation
of a clear hollow [55].
Statistical analysis
Data are expressed as the mean 6 SD of experiments
performed in triplicate and were analyzed for statistical signifi-
cance using a one-way analysis of variance (ANOVA). Differences
with a P-value less than 0.05 were considered statistically
significant for all treatments.
Supporting Information
Figure S1 Predicted amino acid sequence and structure of Bi-
VSP. (A) The deduced amino acid sequence of Bi-VSP (GenBank
accession no. FJ159443). The cleavage site for the predicted signal
sequence (open triangle) is indicated. Cleavage of the catalytic
serine protease domain between Arg113 and Val114 (solid
triangle) was confirmed by N-terminal amino acid sequencing.
Conserved cysteine residues in the clip domain and serine protease
(SP) domain are marked with boxes. Residues in the catalytic triad
of the SP domain [His (H), Asp (D), and Ser (S)] are indicated by
circles. (B) The genomic structure of the Bi-VSP gene (GenBank
accession no. FJ159442) was inferred from an analysis of the Bi-
proVSP cDNA. The numbers indicate the position in the genomic
sequence.
Found at: doi:10.1371/journal.pone.0010393.s001 (1.05 MB TIF)
Figure S2 Amino acid sequence alignment of Bi-VSP with
known PPAFs. Identical residues are shown in solid boxes. The
dashes represent gaps that were introduced to preserve the
alignment. The conserved cysteine residues in the SP domain are
marked (solid squares), and the residues in the catalytic triad of
the SP domain [His (H), Asp (D), and Ser (S)] are indicated with
asterisks. The abbreviations and GenBank accession numbers for
the aligned sequences are: Bi-VSP (this study, FJ159443);
HdPPAF-III, Holotrichia diomphalia PPAF-III (BAC15604);
MsPAP-3, Manduca sexta PAP-3 (AAX18637); Dmeaster, D.
melanogaster easter (NP_524362); HdPPAE-I, H. diomphalia
PPAE-I (BAA34642); MsPAP-1, M. sexta PAP-1 (AAX18636);
and BmPPAE, B. mori PPAE (NP_001036832). The Bi-VSP
sequence was used as a reference for the identity/similarity (Id/
Si) values.
Found at: doi:10.1371/journal.pone.0010393.s002 (3.79 MB TIF)
Figure S3 Amino acid sequence alignment of Bi-VSP with
known snake venom serine proteases. Identical residues are shown
in solid boxes. The dashes represent gaps that were introduced to
preserve the alignment. The conserved cysteine residues in the SP
domain are marked (solid squares), and the residues in the catalytic
triad of the SP domain [His (H), Asp (D), and Ser (S)] are indicated
with asterisks. The abbreviations and GenBank accession numbers
for the aligned sequences are: Bi-VSP (this study, FJ159443),
Oscutarin C (AY940204), Batroxobin (AAA48553), TSV-PA
(Q91516), PA-BJ (P81824), Halystase (P81176), and RVV-V
(P18964). The Bi-VSP sequence was used as a reference for the
identity/similarity (Id/Si) values.
Found at: doi:10.1371/journal.pone.0010393.s003 (3.74 MB TIF)
Figure S4 Northern blot analysis of Bi-VSP. (A) A northern blot
for Bi-VSP was performed using total RNA isolated from the fat
bodies, midgut, muscle, venom glands, and venom sacs of B. ignitus
worker bees. (Top) Ethidium bromide staining of the RNA is
shown to indicate equal loading. (Bottom) Bi-VSP transcripts. (B)
A northern blot for Bi-VSP was performed using total RNA
isolated from whole bodies of worker, male, and queen bees. (Top)
Ethidium bromide staining of the RNA is shown to indicate equal
Bee Venom Serine Protease
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for the worker and queen, but not for the male, which lacks a sting
apparatus.
Found at: doi:10.1371/journal.pone.0010393.s004 (0.68 MB TIF)
Figure S5 Purified recombinant Bi-proVSP. SDS-PAGE (left)
and western blot (right) of recombinant Bi-proVSP purified from
baculovirus-infected insect cells. The anti-Bi-proVSP antibody was
produced in mice injected with recombinant Bi-proVSP.
Found at: doi:10.1371/journal.pone.0010393.s005 (0.64 MB TIF)
Figure S6 Viability of B. mori larvae injected with Bi-VSP. The
viability of day 2 fifth-instar B. mori larvae injected with 1-10 mgo f
Bi-VSP per larva was surveyed at 24 h p.i. The data are expressed
as the mean 6 SD of assays performed in triplicate (n=33).
Found at: doi:10.1371/journal.pone.0010393.s006 (0.62 MB TIF)
Figure S7 Purified recombinant B. mori proPOs expressed in
baculovirus-infected insect Sf9 cells. SDS-PAGE (left) and western
blot (right) of purified recombinant B. mori proPO-I (BmPPO-I)
and proPO-II (BmPPO-II). His-tagged recombinant BmPPO-I
and BmPPO-II were identified using an anti-His antibody. Lane 1,
purified BmPPO-I; lane 2, purified BmPPO-II.
Found at: doi:10.1371/journal.pone.0010393.s007 (0.66 MB TIF)
Figure S8 The mortality of S. exigua larvae injected with Bi-VSP.
Day 2 fifth-instar S. exigua larvae were injected with Bi-VSP (1 mg
or 2 mg per larva). (A) Fifth-instar S. exigua larvae and the collected
hemolymph were photographed at various time points p.i. Scale
bar, 0.5 cm. (B) The accumulated mortality was surveyed at
various time points p.i. The data are expressed as the mean 6 SD
of assays performed in triplicate (n=33).
Found at: doi:10.1371/journal.pone.0010393.s008 (1.09 MB TIF)
Figure S9 Mortality of Bi-VSP, Bi-PLA2, and Bi-Bombolitin in
S. exigua larvae. Day 2 fifth-instar S. exigua larvae were injected with
2 mg/larva of Bi-VSP, Bi-PLA2, Bi-Bombolitin, Bi-VSP + Bi-
PLA2, Bi-PAP + Bi-Bombolitin, Bi-PLA2 + Bi-Bombolitin, or Bi-
VSP + Bi-PLA2 + Bi-Bombolitin. The data are expressed as the
mean 6 SD of three assays (n=51).
Found at: doi:10.1371/journal.pone.0010393.s009 (0.78 MB TIF)
Figure S10 Proposed pathway for PO activation and the
fibrin(ogen)olytic nature of Bi-VSP. The injection of bee venom
via the sting apparatus results in the activation of proPO via Bi-
VSP in the target insect. Elevated PO activity induces the death of
target insects via melanization. In mammals, Bi-VSP not only
activates prothrombin, it also degrades fibrinogen into fibrin
degradation products (FDPs).
Found at: doi:10.1371/journal.pone.0010393.s010 (1.53 MB TIF)
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